Vcanbio Cell & Gene Engineering Corp., Ltd Share Price
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.45 CNY | +0.73% | +6.68% | -18.85% |
Sales 2022 | 1.55B 215M 17.89B | Sales 2023 | 1.59B 219M 18.29B | Capitalization | 9.49B 1.31B 109B |
---|---|---|---|---|---|
Net income 2022 | 113M 15.6M 1.3B | Net income 2023 | 106M 14.63M 1.22B | EV / Sales 2022 | 4.31 x |
Net cash position 2022 | 1.25B 173M 14.41B | Net cash position 2023 | 1.47B 202M 16.86B | EV / Sales 2023 | 5.04 x |
P/E ratio 2022 |
70.9
x | P/E ratio 2023 |
88.1
x | Employees | 2,332 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.64% |
1 day | +0.73% | ||
1 week | +6.68% | ||
Current month | +0.30% | ||
1 month | +2.49% | ||
3 months | -5.24% | ||
6 months | -12.45% | ||
Current year | -18.85% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 30/09/30 |
Xiao Ting Wang
DFI | Director of Finance/CFO | 42 | 25/22/25 |
Hai Bin Li
BRD | Director/Board Member | 53 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 30/09/30 |
Xin Yi Hou
BRD | Director/Board Member | 64 | 19/20/19 |
Hong Qi Wang
BRD | Director/Board Member | 59 | 16/23/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 16.45 | +0.73% | 4,613,369 |
25/24/25 | 16.33 | +1.24% | 4,311,099 |
24/24/24 | 16.13 | +1.38% | 3,420,213 |
23/24/23 | 15.91 | +1.73% | 3,544,628 |
22/24/22 | 15.64 | +1.43% | 4,008,999 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-18.85% | 1.06B | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- 600645 Stock